pharma · Mucopolysaccharidosis type IIIA (Sanfilippo A syndrome)
Esteve Pharmaceuticals
Esteve Química is a pharma organization headquartered in Barcelona, ES. Primary therapeutic focus areas include Mucopolysaccharidosis type IIIA (Sanfilippo A syndrome). NovaPharmaNews links 1 clinical program(s), 0 drug
Barcelona, ES HQ
46 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Barcelona, ES
- Employees
- 46
- Programs
- 1
- Drugs
- 3
- Patents
- 0
ESTEVE-SANF-201
Phase 2 · other · Mucopolysaccharidosis type IIIA (Sanfilippo A syndrome)
ESTEVE-SANF-201 for Mucopolysaccharidosis type IIIA (Sanfilippo A syndrome) is a Phase 2 program (other) at Esteve Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code ESTEVE-SANF-201
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Esteve Pharmaceuticals
- Phase
- Phase 2
- Modality
- other
- Indication
- Mucopolysaccharidosis type IIIA (Sanfilippo A syndrome)
- Status
- active
- Trials
- 1